Experience in 3,500 patients with urinary stones treated with the Dornier HM-4 bath-free lithotriptor
| Autor: | G. Louras, C. Dimopoulos, Athanasios Kostakopoulos, Ch. Deliveliotis, N. I. Stavropoulos |
|---|---|
| Rok vydání: | 1997 |
| Předmět: |
Nephrology
medicine.medical_specialty Staghorn calculus Urology medicine.medical_treatment Urinary system Disease-Free Survival Lithotripsy Internal medicine Humans Medicine Ureteroscopy Retrospective Studies medicine.diagnostic_test business.industry Stent Extracorporeal shock wave lithotripsy Renal pelvic Surgery Treatment Outcome Percutaneous nephrostomy Urinary Calculi Safety business Follow-Up Studies |
| Zdroj: | International Urology and Nephrology. 29:147-153 |
| ISSN: | 1573-2584 0301-1623 |
| DOI: | 10.1007/bf02551334 |
| Popis: | During a 3-year period, hundreds of patients underwent ESWL treatment with the Dornier HM-3 and HM-4 lithotriptors operating at our institution. Our experience in 3,500 patients treated with the HM-4 bath-free lithotriptor is reported. Patients with radiolucent or cystine stones, stones larger than 3 cm or staghorn calculi, multiple stones with a total burden of more than 3 cm and those not amenable to follow-up were excluded from the study. The overall stone-free rate was 70.7% and 81% at 1 and 3 months, respectively. The stone-free rates at 1 and 3 months were further determined by the exact location of each stone within the urinary tract. Stone-free rates at 3 months ranged from 90.84% for renal pelvic stones to 71.08% for lower calyceal stones, while the stone-free rates for ureteral calculi ranged from 80.85% for upper third unstented ureteral stones to 92.92% for lower ureteral stones. The overall complication rate was 6.02% with a 1.2% post-ESWL intervention rate (ureteroscopy or placement of percutaneous nephrostomy or stent). |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink